Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GenMark Diagnostics Inc. GNMK

Healthcare
GenMark Diagnostics Inc is a provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The company currently operates in one reportable business segment, which encompasses the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary... see more

Recent & Breaking News (NDAQ:GNMK)

GenMark Reports First Quarter 2016 Results

Business Wire May 3, 2016

GenMark Diagnostics Schedules First Quarter 2016 Financial Results Conference Call for May 3, 2016

Business Wire April 19, 2016

GenMark Reports Fourth Quarter and Full Year 2015 Results

Business Wire February 23, 2016

GenMark Announces Preliminary Q4 Financial Results and Initiation of ePlex(TM) Analytical Studies

Business Wire January 12, 2016

GenMark Diagnostics to Present at the 2016 J.P. Morgan Healthcare Conference

Business Wire December 30, 2015

GenMark Diagnostics Reports Q3 Financial Results

Business Wire October 27, 2015

GenMark Diagnostics Schedules Third Quarter 2015 Financial Results Conference Call for October 27, 2015

Business Wire October 15, 2015

GenMark Diagnostics Reports Q2 Financial Results

Business Wire August 6, 2015

GenMark Diagnostics to Present at the 35th Annual Canaccord Genuity Growth Conference

Business Wire July 30, 2015

GenMark Diagnostics Schedules Second Quarter 2015 Financial Results Conference Call for August 6, 2015

Business Wire July 21, 2015

GenMark Diagnostics to Present at the William Blair 35th Annual Growth Stock Conference

Business Wire May 27, 2015

GenMark Diagnostics Reports Q1 Financial Results

Business Wire May 5, 2015

GenMark Diagnostics to Present at Bank of America Merrill Lynch 2015 Health Care Conference

Business Wire April 29, 2015

GenMark Announces Positive Preliminary Q1 Financial Results and ePlex(TM) Update

Business Wire April 16, 2015

GenMark Reports Fourth Quarter and Full Year 2014 Results

Business Wire February 24, 2015

GenMark Announces Appointment of New Board Members

Business Wire February 23, 2015

GenMark Diagnostics to Present at Two Upcoming Investor Conferences

Business Wire February 17, 2015

GE Capital Agents $40 Million Credit Facility for GenMark Diagnostics

Business Wire January 13, 2015

GenMark Announces Completion of ePlex(TM) Development and Preliminary Q4 Financial Results

Business Wire January 12, 2015

GenMark Diagnostics to Present at the 2015 J.P. Morgan Healthcare Conference

Business Wire December 30, 2014